20 November 2018,"Clinical Study on Efficacy, Safety and Economics of Sultamicillin for Suspension in the Treatment of Children with Mild to Moderate Acute Bacterial Lower Respiratory Tract Infection", Beijing Children's Hospital Initiation Meeting was officially held in the Department of Internal Medicine on the 3rd Floor of Outpatient Building of Beijing Children's Hospital Affiliated to Capital Medical University. The launch will be chaired by Zhao Chengsong, an infectious medicine specialist, and a number of researchers from the department attended the discussion.

Director Zhao Chengsong made a speech and introduced the project:

Quality Control Teacher Song Lijuan introduced GCP and related contents of quality control:

Clinical monitor Tao Shibin introduced the protocol, drug, informed consent form and information filling related contents:

At the meeting, the participating teachers discussed the problems of this experiment. In order to ensure the smooth clinical progress, the final confirmation was made on the CRF completion, the range of the subject's age at enrollment, and the necessity of chest X-ray examination at the time of enrollment.

The successful implementation of this launch meeting indicates the formal start of this multi-center clinical study, and other relevant hospitals will also carry out the start-up meeting in the future to carry out the follow-up work of case enrollment. Let us look forward to the smooth development and conduct of the multi-center clinical study project of "sultamicillin for suspension".